Xenon Pharmaceuticals is developing a drug for the most common type of seizure experienced by people with epilepsy. Here's ...

Wolfe Research’s new coverage of Xenon Pharmaceuticals (NasdaqGM:XENE) with a favorable rating has brought fresh attention to the stock, as investors reassess the company’s neuroscience pipeline and ...

Phase 3 X-TOLE2 topline data for azetukalner in FOS expected first half of March 2026Five additional Phase 3 studies of azetukalner continue to ...

nasdaq composite visibility underscores the company’s presence within broader healthcare and innovation-driven market discussions ...

Xenon Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating ...

Most climbers take several months to scale Mount Everest, gradually heading up and down to acclimatize to the lack of oxygen. British politician Alistair Carns says he is aiming to do it in just four ...

This biotech specializes in clinical-stage therapies for neurological disorders, with a pipeline targeting epilepsy and ...

"Hearst Magazines and Yahoo may earn commission or revenue on some items through these links." IF YOU COULD scale Everest and back in less than a week, would you do it? That's exactly what a British ...

Nighttime driving these days can turn into a dazzling — even blinding — light show from the different types of headlights available on newer vehicles. The familiar warm, yellow glow cast by halogen ...

Anil Oza is a general assignment reporter at STAT focused on the NIH and health equity. You can reach him on Signal at aniloza.16. The gas xenon, like the other noble, or inert, gases, is known for ...

The paradox of the missing xenon might sound like the title of the latest airport thriller, but it's actually a problem that's stumped geophysicists for decades. New work provides the first ...